Molecular targeted study in tumors: From western medicine to active ingredients of traditional Chinese medicine

被引:27
作者
Li, Ruixiao [1 ,2 ]
Li, Qi [1 ,2 ,3 ]
Ji, Qing [1 ,2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, 528 Zhangheng Rd, Shanghai 201203, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Canc Inst, 528 Zhangheng Rd, Shanghai 201203, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor; Targeted therapy; Western medicine; Traditional Chinese medicine; Ingredient; BREAST-CANCER CELLS; FOCAL ADHESION KINASE; BETULINIC ACID; HEPATOCELLULAR-CARCINOMA; DRUG DISCOVERY; NETWORK PHARMACOLOGY; RAF/MEK/ERK PATHWAY; SIGNALING PATHWAYS; LUNG METASTASIS; RECEPTOR-ALPHA;
D O I
10.1016/j.biopha.2019.109624
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Malignant tumor has been always endangering human health, and its morbidity and mortality have been increasing year by year. At present, the main clinical treatment of malignant tumors is surgery, radiotherapy and chemotherapy, but it is difficult to achieve satisfactory prognosis. In recent years, targeted therapy for various tumors has been more and more popular. Molecular targeted drugs are mainly targeted at key targets in the development of malignant tumors. Some molecular targeted drugs have shown good results in the corresponding tumor treatment. More and more molecular targeted drugs have been developed and produced due to the well understanding of the molecular targets and involved pathways of tumorigenesis and development. In this review, we will summarize the direct targets of western medicine targeted drugs and traditional Chinese medicine monomers, as well the study methods about molecular targets. The purpose of this review is to seek the best ways to find out the targets and pathways of the active ingredients of traditional Chinese medicine by referring to the research methods of western medicine.
引用
收藏
页数:12
相关论文
共 131 条
[11]  
[Anonymous], ANTITUMOR PHARM
[12]  
[Anonymous], RAND PROSP MULT TRIA
[13]   Bioorganic synthesis of lipid-modified proteins for the study of signal transduction [J].
Bader, B ;
Kuhn, K ;
Owen, DJ ;
Waldmann, H ;
Wittinghofer, A ;
Kuhlmann, J .
NATURE, 2000, 403 (6766) :223-226
[14]   Murine Prostate Cancer Inhibition by Dietary Phytochemicals-Curcumin and Phenyethylisothiocyanate [J].
Barve, Avantika ;
Khor, Tin Oo ;
Hao, Xingpei ;
Keum, Young-Sam ;
Yang, Chung S. ;
Reddy, Bandaru ;
Kong, Ah-Ng Tony .
PHARMACEUTICAL RESEARCH, 2008, 25 (09) :2181-2189
[15]   Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex [J].
Beevers, Christopher S. ;
Chen, Long ;
Liu, Lei ;
Luo, Yan ;
Webster, Nicholas J. G. ;
Huang, Shile .
CANCER RESEARCH, 2009, 69 (03) :1000-1008
[16]   A Genetic Engineering Solution to the "Arginine Conversion Problem" in Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) [J].
Bicho, Claudia C. ;
Alves, Flavia de Lima ;
Chen, Zhuo A. ;
Rappsilber, Juri ;
Sawin, Kenneth E. .
MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (07) :1567-1577
[17]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[18]   α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration [J].
Boggs, Amanda E. ;
Vitolo, Michele I. ;
Whipple, Rebecca A. ;
Charpentier, Monica S. ;
Goloubeva, Olga G. ;
Ioffe, Olga B. ;
Tuttle, Kimberly C. ;
Slovic, Jana ;
Lu, Yiling ;
Mills, Gordon B. ;
Martin, Stuart S. .
CANCER RESEARCH, 2015, 75 (01) :203-215
[19]   Drug design using the example of the complement system inhibitors' development [J].
Bureeva, S ;
Andia-Pravdivy, J ;
Kaplun, A .
DRUG DISCOVERY TODAY, 2005, 10 (22) :1535-1542
[20]   Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model [J].
Busquets, S ;
Carbó, N ;
Almendro, V ;
Quiles, MT ;
López-Soriano, FJ ;
Argilés, JM .
CANCER LETTERS, 2001, 167 (01) :33-38